Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of hepatitis C in HIV-infected patients: regularly reassess the benefits and risks.

Prescrire international - 1 Dec 2005

Abstract excerpt

(1) HIV-infected patients appear to be at an increased risk of complications of hepatitis C virus (HCV) infection. (2) Treatments for hepatitis C have been assessed in four open-label randomised controlled trials involving more than 1500 HIV-infected patients. Only virological endpoints were assessed. Patients with low CD4 lymphocyte counts were excluded, and few patients had cirrhosis. (3) Only one of these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acidosis, Lactic
Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Cost-Benefit Analysis

Share to Drug Interactions

Share to Fibrosis

Share to Interferon alpha-2

Source

Identifiers

PMID: 16400748

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of hepatitis C in HIV-infected patients: regularly reassess the benefits and risks.PMID 16400748Read ↗

The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis.Semantic proximity Read ↗

Management of hepatitis C/HIV coinfection.Semantic proximity Read ↗

[Management of HCV-HIV patients].Semantic proximity Read ↗

Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts.Semantic proximity Read ↗

Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.Semantic proximity Read ↗

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.Semantic proximity Read ↗

Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects.Semantic proximity Read ↗

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.Semantic proximity Read ↗

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.Semantic proximity Read ↗

Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients.Semantic proximity Read ↗

Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.Semantic proximity Read ↗

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.